An alternative to hysterectomy? GnRH analogue combined with hormone replacement therapy

K F Gangar, William Stones, R W Stones, Dawn E. Saunders, D Saunders, V. Rogers, Toni Rae, T Rae, S Cooper, Sherrie Cooper, Susan Cooper, R. W. Beard
British journal of obstetrics and gynaecology · 1993 · vol. 100(4) , pp. 360–364 · doi:10.1111/j.1471-0528.1993.tb12980.x · PMID:8494837 · W2158345813
Non-randomised trial OA: closed CC0 ⤵ 11 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study investigated GnRH analogue combined with hormone replacement therapy for chronic pelvic pain, finding it maintained endometrial atrophy and amenorrhea but did not relieve pain.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To assess whether GnRH analogues are effective in relieving pelvic pain and congestion and whether menopausal symptoms caused by GnRH analogues can be minimised by supplementation with low dose continuous combined hormone replacement therapy (HRT). DESIGN: Open prospective study. SETTING: Tertiary referral clinic at a teaching hospital. PATIENTS: Twenty-one women with chronic pelvic pain. INTERVENTION: Four months' therapy with goserelin 3.6 mg/month combined with continuous oestradiol valerate 1 mg daily and medroxyprogesterone acetate 5 mg daily. MAIN OUTCOME MEASURES: Visual analogue scale for pain, menopausal symptoms, bleeding patterns, uterine area, endometrial status, oestradiol concentrations and venogram scores. RESULTS: Amenorrhoea was maintained in all but two women. Endometrial atrophy was maintained despite HRT supplementation. Two women had moderate menopausal symptoms but none had severe symptoms. Significant reduction of uterine cross sectional area was maintained throughout the study. There was no significant relief of pain. CONCLUSIONS: HRT supplementation of GnRH analogues abolishes menopausal symptoms and thus may improve patient acceptability. Potentially beneficial effects such as endometrial atrophy, reduction of uterine volume and amenorrhoea were not negated by HRT. This combination is not effective in the treatment of chronic pelvic pain and congestion.

My notes (saved in your browser only)

Condition tags

chronic_pelvic_pain

MeSH descriptors

Estradiol Estrogen Replacement Therapy Goserelin Medroxyprogesterone Acetate Pelvic Inflammatory Disease Adult Chronic Disease Estradiol Estradiol Female Goserelin Goserelin Humans Hysterectomy Medroxyprogesterone Acetate Menopause Menopause Pain Measurement Patient Satisfaction Pelvic Inflammatory Disease

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (25)

Cited by (9)

Source provenance

openalex
last seen: 2026-05-11T06:18:49.075943+00:00
pubmed
last seen: 2026-10-08T21:59:37.277143+00:00
unpaywall
last seen: 2026-10-15T06:24:24.424788+00:00
License: CC0 · commercial use OK